Copenhagen, Denmark; November 5, 2012 – Genmab A/S (OMX: GEN) announced today that six daratumumab and one ofatumumab abstract have been accepted for presentation at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition December 8-11 in Atlanta, Georgia. The abstracts are available on the ASH website at www.hematology.org.
